Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 25, 2017
Structural bowel damage in quiescent Crohn's diseaseMarianne M Amitai, Moran Zarchin, Adi Lahat, et al.
Journal of Crohn'S & Colitis|November 29, 2017
Capsule Endoscopy Validation of the Magnetic Enterography Global Score in Patients with Established Crohn's DiseaseEyal Klang, Marianne M Amitai, Adi Lahat, et al.
Patient Preference and Adherence|June 30, 2016
Magnetic resonance enterography or video capsule endoscopy - what do Crohn's disease patients prefer?Adi Lahat, Uri Kopylov, Marianne M Amitai, et al.
Medicine|May 8, 2015
Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failureBella Ungar, Ola Haj-Natour, Uri Kopylov, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn's diseaseUri Kopylov, Eyal Klang, Doron Yablecovitch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2015
Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled TrialAlon Lang, Nir Salomon, Justin C Y Wu, et al.
Therapeutic Advances in Gastroenterology|October 23, 2019
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a <i>post hoc</i> analysisDoron Yablecovitch, Uri Kopylov, Adi Lahat, et al.
The American Journal of Gastroenterology|June 6, 2018
Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The POETIC StudyBella Ungar, Tal Engel, Doron Yablecovitch, et al.
Vaccines|March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli ExperienceLev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
Pageof 6